TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmavizer AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
44
|
88
|
442 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-8
|
-5
|
361 |
| EBITDA |
-9
|
-5
|
361 |
| Total assets |
508
|
608
|
689 |
| Current assets |
294
|
395
|
457 |
| Current liabilities |
54
|
140
|
156 |
| Equity capital |
427
|
431
|
493 |
| - share capital |
34
|
33
|
36 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
84.1%
|
70.9%
|
71.6% |
| Turnover per employee |
44
|
88
|
442 |
| Profit as a percentage of turnover |
-18.2%
|
-5.7%
|
81.7% |
| Return on assets (ROA) |
-1.6%
|
-0.8%
|
52.4% |
| Current ratio |
544.4%
|
282.1%
|
292.9% |
| Return on equity (ROE) |
-1.9%
|
-1.2%
|
73.2% |
| Change turnover |
-44
|
-319
|
234 |
| Change turnover % |
-50%
|
-78%
|
113% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.